These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22594680)

  • 1. A novel approach to the analysis of human growth.
    Gliozzi AS; Guiot C; Delsanto PP; Iordache DA
    Theor Biol Med Model; 2012 May; 9():17. PubMed ID: 22594680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noonan syndrome: growth and clinical manifestations in 144 cases.
    Ranke MB; Heidemann P; Knupfer C; Enders H; Schmaltz AA; Bierich JR
    Eur J Pediatr; 1988 Dec; 148(3):220-7. PubMed ID: 3215198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Growth Characteristics of Patients with Noonan Syndrome: Results of Three Years of Growth Hormone Treatment: A Nationwide Multicenter Study.
    Şıklar Z; Genens M; Poyrazoğlu Ş; Baş F; Darendeliler F; Bundak R; Aycan Z; Savaş Erdeve Ş; Çetinkaya S; Güven A; Abalı S; Atay Z; Turan S; Kara C; Can Yılmaz G; Akyürek N; Abacı A; Çelmeli G; Sarı E; Bolu S; Korkmaz HA; Şimşek E; Çatlı G; Büyükinan M; Çayır A; Evliyaoğlu O; İşgüven P; Özgen T; Hatipoğlu N; Elhan AH; Berberoğlu M
    J Clin Res Pediatr Endocrinol; 2016 Sep; 8(3):305-12. PubMed ID: 27125300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth in Noonan syndrome.
    Otten BJ; Noordam C
    Horm Res; 2009 Dec; 72 Suppl 2():31-5. PubMed ID: 20029234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human stature: which growth model?
    Jolicoeur P; Abidi H; Pontier J
    Growth Dev Aging; 1991; 55(2):129-32. PubMed ID: 1938046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult height in Noonan syndrome.
    Noonan JA; Raaijmakers R; Hall BD
    Am J Med Genet A; 2003 Nov; 123A(1):68-71. PubMed ID: 14556249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of growth hormone therapy in children with noonan syndrome: a review of the evidence.
    Noonan JA; Kappelgaard AM
    Horm Res Paediatr; 2015; 83(3):157-66. PubMed ID: 25503994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth curves for height in Noonan syndrome.
    Witt DR; Keena BA; Hall JG; Allanson JE
    Clin Genet; 1986 Sep; 30(3):150-3. PubMed ID: 3780030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.
    Binder G; Neuer K; Ranke MB; Wittekindt NE
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5377-81. PubMed ID: 15985475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone treatment in Noonan syndrome: report of four cases who reached final height.
    Municchi G; Pasquino AM; Pucarelli I; Cianfarani S; Passeri F
    Horm Res; 1995; 44(4):164-7. PubMed ID: 8522277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of adult height prediction based on automated bone age determination in the Paris Longitudinal Study of healthy children.
    Martin DD; Schittenhelm J; Thodberg HH
    Pediatr Radiol; 2016 Feb; 46(2):263-9. PubMed ID: 26573823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and clinical assessment in 45 patients with Noonan syndrome.
    Yoshida R; Hasegawa T; Hasegawa Y; Nagai T; Kinoshita E; Tanaka Y; Kanegane H; Ohyama K; Onishi T; Hanew K; Okuyama T; Horikawa R; Tanaka T; Ogata T
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3359-64. PubMed ID: 15240615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone treatment in Noonan syndrome.
    Tanaka T
    Acta Paediatr Jpn; 1996 Feb; 38(1):99-101. PubMed ID: 8992871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone therapy in pre-pubertal children with Noonan syndrome: first year growth response and comparison with Turner syndrome.
    De Schepper J; Otten BJ; François I; Bourguignon JP; Craen M; Van der Burgt I; Massa GG
    Acta Paediatr; 1997 Sep; 86(9):943-6. PubMed ID: 9343272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone (GH) secretion in children with Noonan syndrome: frequently abnormal without consequences for growth or response to GH treatment.
    Noordam C; van der Burgt I; Sweep CG; Delemarre-van de Waal HA; Sengers RC; Otten BJ
    Clin Endocrinol (Oxf); 2001 Jan; 54(1):53-9. PubMed ID: 11167926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short stature and its treatment in Turner and Noonan syndromes.
    Chacko EM; Rapaport R
    Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):40-6. PubMed ID: 22157403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noonan syndrome: growth to growth hormone - the experience of observational studies.
    Ranke MB
    Horm Res; 2009 Dec; 72 Suppl 2():36-40. PubMed ID: 20029235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone therapy in Noonan syndrome: growth response and characteristics.
    Westphal O
    Horm Res; 2009 Dec; 72 Suppl 2():41-5. PubMed ID: 20029236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic standards for body weight.
    Hermanussen M; Meigen C
    Homo; 2003; 54(2):142-56. PubMed ID: 14740364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early anthropometric indices predict short stature and overweight status in a cohort of Peruvians in early adolescence.
    Sterling R; Miranda JJ; Gilman RH; Cabrera L; Sterling CR; Bern C; Checkley W
    Am J Phys Anthropol; 2012 Jul; 148(3):451-61. PubMed ID: 22552904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.